Document is current
Any future updates will be listed below
-
Authors
Karam, A.
Bricout, N.
Khyeng, M.
Cordonnier, C.
Leclerc, X.
Henon, H.
Casolla, B. https://orcid.org/0000-0003-4199-995X
-
Funding
Funding for this research was provided by:
Inserm U 1172 ADRINORD
- License Information
-
More Information
Article History
Received: 22 February 2021
Revised: 30 April 2021
Accepted: 9 June 2021
First Online: 29 June 2021
Declarations
:
: Arnaud Karam, Maeva Khyeng and Nicolas Bricout declare that they have no conflict of interest. Barbara Casolla and Hilde Henon served as investigator for clinical trials (Astra-Zeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Pfizer). All fees were paid to ADRINORD or the Lille University Hospital research account, no personal funding. Charlotte Cordonnier served for advisory boards (Bayer, Medtronics, Daiichi-Sankyo) and an investigator for clinical trials (Astra-Zeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Pfizer). All fees were paid to ADRINORD or the Lille University Hospital research account, no personal funding.
: The ethical committee (Comité de protection des personnes Nord Ouest IV) classified the study as observational on March 9, 2010 and approved the study by December 21, 2010(n° 10. 677). The patient and their relatives gave an informed consent to participate. All the performed procedures were part of the routine care.
